Evidence map›Paper›PMID 22763484›Full record

ArticleHypertension research : official journal of the Japanese Society of Hypertension2012

Therapeutic potential of Schisandra chinensis extracts for treatment of hypertension. Introduction to: 'antihypertensive effect of gomisin A from Schisandra chinensis on angiotensin II-induced hypertension via preservation of nitric oxide bioavailability' by Park et al.

Jonathan Steven Alexander, Yuping Wang

Open access · bronzeAbstract readComment
PubMed Publisher
In one paragraph

Article in Hypertension research : official journal of the Japanese Society of Hypertension, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Current knowledge ofPhytochemistry reviews : proceedings of the Phytochemical Society of Europe · 2017
    Review
  8. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Jonathan Steven AlexanderDepartment of Molecular & Cellular Physiology, LSU Health Sciences Center, Shreveport, LA, USA. jalexa@lsuhsc.edu
Yuping Wang
Louisiana State University Health Sciences Center Shreveport · US

Funding

ENDOTHELIAL BARRIER FUNCTION IN PREECLAMPSIAR01HL065997 · NHLBI · LOUISIANA STATE UNIV HSC SHREVEPORT · PI WANG, YUPING · 2001 to 2010
$1.8M
PLACENTAL FUNCTION IN PREECLAMPSIAR01HD036822 · NICHD · LOUISIANA STATE UNIV HSC SHREVEPORT · PI WANG, YUPING · 1999 to 2009
$1.3M
NHLBI NIH HHS R01 HL065997NICHD NIH HHS R01 HD036822
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Angiotensin IIAntihypertensive AgentsVasoconstrictor AgentsAnimalsCyclooctanesDioxolesHypertensionLignansMaleNitric OxideSchisandraAngiotensin IIAntihypertensive AgentsCyclooctanesDioxolesLignansNitric Oxideschizandrol BVasoconstrictor Agents

Identifiers

PMID22763484
OpenAlexW1969081918

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.